• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Amicus Therapeutics Inc

+ Add to Watchlist

AM6:GR

3.274 EUR 0.078 2.44%

As of 02:05:59 ET on 07/31/2014.

Snapshot for Amicus Therapeutics Inc (AM6)

Open: 3.270 Day's Range: 3.270 - 3.274 Volume: 0
Previous Close: 3.196 52wk Range: 1.287 - 3.409 1-Yr Rtn: +86.66%

Stock Chart for AM6

No chart data available.
  • AM6:GR 3.273
  • 1D
  • 1M
  • 1Y
3.196
Interactive AM6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AM6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.9300
Est. PEG Ratio -
Market Cap (M EUR) 210.65
Shares Outstanding (M) 64.34
30 Day Average Volume 341
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AM6

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AM6

Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

John F CrowleyChairman/CEOWilliam D Baird III "Chip"Chief Financial Officer
Bradley L CampbellChief Operating OfficerJay BarthChief Medical Ofcr
More Company Profile & Key Executives for AM6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil